VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer. Issue 11 (November 2018)
- Record Type:
- Journal Article
- Title:
- VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer. Issue 11 (November 2018)
- Main Title:
- VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer
- Authors:
- Beysel, Selvihan
Eyerci, Nilnur
Pinarli, Ferda Alparslan
Apaydin, Mahmut
Kizilgul, Muhammed
Caliskan, Mustafa
Ozcelik, Ozgur
Kan, Seyfullah
Cakal, Erman - Abstract:
- This is the first study to investigate the effect of vitamin D receptor ( VDR ) gene single-nucleotide polymorphisms on the clinicopathologic features of papillary thyroid cancer in Turkey. A total of 165 patients with papillary thyroid cancer and 172 controls were included in this case–control study. VDR gene single-nucleotide polymorphisms FokI (rs2228570), BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236) were evaluated using reverse-transcription polymerase chain reaction. VDR gene polymorphisms BsmI, ApaI, and TaqI did not differ between the papillary thyroid cancer group and control group (p > 0.05, each). BsmI, ApaI, and TaqI were not associated with papillary thyroid cancer risk. The VDR gene FokI CT/TT genotype was associated with an increased papillary thyroid cancer risk (CT vs CC: odds ratio = 1.71, 95% confidence interval = 1.15–2.76, p = 0.028; TT vs CC: odds ratio = 2.44, 95% confidence interval = 1.29–4.62, p = 0.005; CT/TT vs CC: odds ratio = 1.88, 95% confidence interval = 1.20–2.96, p = 0.006; CT/CC vs TT: odds ratio = 1.80, 95% confidence interval = 1.05–3.20, p = 0.041). VDR gene polymorphisms were not in linkage disequilibrium. The FokI TT genotype was associated with having T3 and T4, stage III/IV, extra-thyroidal invasion. The FokI CT/TT or TT genotype was associated with developing N1 status, multifocality, tumor size ≥10 mm, and treatment with radioiodine therapy. Persistence/recurrence did not differ between the FokI genotypes. Carriers ofThis is the first study to investigate the effect of vitamin D receptor ( VDR ) gene single-nucleotide polymorphisms on the clinicopathologic features of papillary thyroid cancer in Turkey. A total of 165 patients with papillary thyroid cancer and 172 controls were included in this case–control study. VDR gene single-nucleotide polymorphisms FokI (rs2228570), BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236) were evaluated using reverse-transcription polymerase chain reaction. VDR gene polymorphisms BsmI, ApaI, and TaqI did not differ between the papillary thyroid cancer group and control group (p > 0.05, each). BsmI, ApaI, and TaqI were not associated with papillary thyroid cancer risk. The VDR gene FokI CT/TT genotype was associated with an increased papillary thyroid cancer risk (CT vs CC: odds ratio = 1.71, 95% confidence interval = 1.15–2.76, p = 0.028; TT vs CC: odds ratio = 2.44, 95% confidence interval = 1.29–4.62, p = 0.005; CT/TT vs CC: odds ratio = 1.88, 95% confidence interval = 1.20–2.96, p = 0.006; CT/CC vs TT: odds ratio = 1.80, 95% confidence interval = 1.05–3.20, p = 0.041). VDR gene polymorphisms were not in linkage disequilibrium. The FokI TT genotype was associated with having T3 and T4, stage III/IV, extra-thyroidal invasion. The FokI CT/TT or TT genotype was associated with developing N1 status, multifocality, tumor size ≥10 mm, and treatment with radioiodine therapy. Persistence/recurrence did not differ between the FokI genotypes. Carriers of the FokI T allele were at an increased risk of more advanced tumor-node-metastasis stage, greater tumor size, multifocality, and extra-thyroidal invasion of papillary thyroid cancer compared with the CC genotype. VDR gene FokI T allele and TT genotype correlated with aggressiveness of papillary thyroid cancer; thus, FokI could be useful as a poor prognostic factor to assess the high risk of papillary thyroid cancer. … (more)
- Is Part Of:
- Tumor biology. Volume 40:Issue 11(2018)
- Journal:
- Tumor biology
- Issue:
- Volume 40:Issue 11(2018)
- Issue Display:
- Volume 40, Issue 11 (2018)
- Year:
- 2018
- Volume:
- 40
- Issue:
- 11
- Issue Sort Value:
- 2018-0040-0011-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-11
- Subjects:
- VDR gene -- papillary thyroid cancer -- FokI polymorphism
Cancer -- Periodicals
Oncology -- Periodicals
Tumors -- Periodicals
616.994 - Journal URLs:
- https://www.iospress.nl/journal/tumor-biology/ ↗
https://uk.sagepub.com/en-gb/eur/tumor-biology/journal202707 ↗
http://www.springer.com/gb/ ↗ - DOI:
- 10.1177/1010428318811766 ↗
- Languages:
- English
- ISSNs:
- 1010-4283
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9070.645500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8951.xml